Drugs / AdhAQP1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00372320 | Sep 2006 → Mar 2014 | parotid disorder | National Institute of Dental and Craniofacial Research (NIDCR) | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AdhAQP1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00372320 ↗ |
| Action | Restore | “strategy for restoring salivary flow to IR-damaged salivary glands” NCT00372320 ↗ |
| Route | Other | “administration, through a catheter, of the study drug AdhAQP1 into one parotid gland” NCT00372320 ↗ |
| Target | AQP1 | “transferring the human aquaporin-1 (hAQP1) cDNA to parotid glands” NCT00372320 ↗ |